세계의 주사 치료 시장 : 약제 클래스별, 투여 경로별, 유형별, 유통 채널별, 지역별
Rosacea Treatment Market, By Drug Class, By Route of Administration, By Type, By Distribution Channel, By Geography
상품코드
:
1741215
리서치사
:
Coherent Market Insights
발행일
:
2025년 03월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 주사 치료 시장은 2025년 21억 6,000만 달러로 추정되고, 2032년까지 33억 6,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 6.5%를 보일 것으로 예측됩니다.
| 보고 범위 |
보고서 세부정보 |
| 기준연도 |
2024년 |
2025년 시장 규모 |
21억 6,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측기간 2025-2032년 CAGR: |
6.50% |
2032년 가치 예측 |
33억 6,000만 달러 |
주사는 얼굴 붉어짐, 조홍, 때로는 고름을 일으키는 특징적인 만성 피부 질환입니다. 용약, 내복약, 레이저 치료, 빛에 의한 치료, 스킨 케어 제품 등 다양한 치료 옵션이 제공되고 있습니다. 주사의 실제 병인은 불분명하지만, 유전, 환경적 유인, 일부 약제 등, 많은 요인이 관여하고 있다고 생각됩니다.
시장 역학:
인지도와 진단의 향상이 예측 기간 중에도 세계의 주사 치료 시장의 성장을 가속한다고 생각됩니다. 전 세계에서 수백만 명이 앓고 있는 광범위한 만성 피부 질환이 주류입니다.
사용 가능한 치료법의 효능이 제한되어 있다는 것은 예측 기간 동안 주사 치료 세계 시장의 성장을 방해할 것으로 예측됩니다.
본 조사의 주요 특징
- 본 보고서에서는 세계의 주사 치료 시장을 상세하게 분석했으며, 2024년을 기준연도로 한 예측 기간 2025-2032년 시장 규모 및 연간 평균 성장률(CAGR%)을 제공합니다.
- 또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
- 또 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 세계의 주사 치료 시장의 주요 기업을 프로파일 하고 있습니다.
- 본 보고서로부터의 통찰에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 발매, 유형, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
- 세계의 주사 치료 시장 보고서는 투자자, 공급자, 제품 제조업체, 유통업체, 신규 참가자, 재무 애널리스트 등, 이 업계의 다양한 이해 관계자에 대응하고 있습니다.
- 이해관계자는 세계의 주사 치료 시장의 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 술의 유병률 증가
- 이용 가능한 치료법의 유효성이 한정되어 있음
- 혁신적인 치료법의 창출
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- 파이프라인 분석
- PORTER 분석
- 합병과 인수 시나리오
제4장 코로나바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측 분석
- 경제에 미치는 영향
제5장 주사 치료 시장 : 약제 클래스별, 2020-2032년
- 항생제
- 알파 작용제
- 레티노이드
- 코르티코스테로이드
- 면역억제제
- 기타 약물 클래스
제6장 주사 치료 시장 : 투여 경로별, 2020-2032년
제7장 주사 치료 시장 : 유형별, 2020-2032년
- 홍반 모세 혈관 확장성 주사
- 구진 농포성 주사
- 안구 주사
- 피마토이드 주사
제8장 주사 치료 시장 : 유통 채널별, 2020-2032년
제9장 주사 치료 시장 : 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 레인 아메리카
- 브라질
- 멕시코
- 아르헨티나
- 기타 라틴아메리카
- 유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- 아프리카
제10장 경쟁 구도
- Galderma
- Allergan
- Bayer
- Foamix Pharmaceuticals
- Mayne Pharma
- Leo Pharma
- Pfizer
- Dermira
- Nestle Skin Health
- Aclaris Therapeutics
제11장 섹션
JHS
영문 목차
Rosacea Treatment Market is estimated to be valued at USD 2.16 Bn in 2025 and is expected to reach USD 3.36 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 2.16 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
6.50% |
2032 Value Projection: |
USD 3.36 Bn |
Rosacea is a chronic skin condition characterized by redness, flushing, and sometimes small, pus-filled bumps on the face. It can be a frustrating condition to manage but there are various treatment options available. In order to cure the symptoms of rosacea and enhance patients' quality of life, the market offers a variety of treatment choices, including topical drugs, oral medications, laser therapies, light-based treatments, and skin care products, among others. The actual etiology of rosacea is unknown, but a number of factors, including genetics, environmental triggers, and some drugs, are likely to be involved.
Market Dynamics:
Increasing recognition and diagnosis will continue to fuel the growth of the global rosacea treatment market over the forecast period. Both patients and medical professionals now have a better grasp of rosacea. Rising rosacea prevalence will also continue to fuel the growth of the global rosacea treatment market over the forecast period. A widespread chronic skin disorder that affects millions of individuals worldwide is rosacea. The creation of innovative therapies will create new opportunities for the global rosacea treatment market over the forecast period. The creation of brand-new, better treatments for rosacea is constantly needed.
Limited efficacy of available treatments is expected to hamper the growth of the global rosacea treatment market over the forecast period. Despite the fact that there are numerous rosacea treatment choices, not all patients have good outcomes.
Key features of the study:
- This report provides an in-depth analysis of the global rosacea treatment market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global rosacea treatment market based on the following parameters - company highlights, product portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Galderma, Allergan, Bayer, Foamix Pharmaceuticals, Mayne Pharma, Leo Pharma, Pfizer, Dermira, Nestle Skin Health, Aclaris Therapeutics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global rosacea treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rosacea treatment market
Detailed Segmentation:
- Global Rosacea Treatment Market, By Drug Class:
- Antibiotics
- Alpha agonists
- Retinoids
- Corticosteroids
- Immunosuppressants
- Other drug classes
- Global Rosacea Treatment Market, By Route of Administration:
- Global Rosacea Treatment Market, By Type:
- Erythematotelangiectatic rosacea
- Papulopustular rosacea
- Ocular rosacea
- Phymatous rosacea
- Global Rosacea Treatment Market, By Distribution Channel:
- Hospitals Pharmacies
- Retail pharmacies
- Online pharmacies
- Global Rosacea Treatment Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profile:
- Galderma
- Allergan
- Bayer
- Foamix Pharmaceuticals
- Mayne Pharma
- Leo Pharma
- Pfizer
- Dermira
- Nestle Skin Health
- Aclaris Therapeutics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Rosacea Treatment, By Drug Class
- Market Rosacea Treatment, By Route of Administration
- Market Rosacea Treatment, By Type
- Market Rosacea Treatment, By Distribution Channel
- Market Rosacea Treatment, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising Rosacea Prevalence
- Limited efficacy of available treatments
- Creation of innovative therapies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- Pipeline Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Rosacea Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Rosacea Treatment Market, By Drug Class, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Alpha agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Retinoids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Immunosuppressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Other drug classes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
6. Rosacea Treatment Market, By Route of Administration, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
7. Rosacea Treatment Market, By Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Erythematotelangiectatic rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Papulopustular rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Ocular rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Phymatous rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
8. Rosacea Treatment Market, By Distribution Channel, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
9. Rosacea Treatment Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth,By Country, 2020 - 2032, (US$ Bn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Galderma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Allergan
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bayer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Foamix Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mayne Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Leo Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Dermira
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Nestle Skin Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Aclaris Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
관련자료
